Xenobiotic Detection Systems (XDS) is a research based biotechnology company offering a patented unique, rapid, and economical bioassay for analyzing dioxin and dioxin-like compounds, including PCBs, dibenzodioxins, and dibenzofurans, with detection limits of less than one part per trillion. XDS has also developed reporter bioassay systems for endocrine disruptors. These systems identify estrogen agonists as well as antagonists by measuring receptor mediated transcriptional activation. This activity can be measured in pure compounds or in extracts. XDS has licensed its technology, set up laboratories, and provided staff training to the Arkansas Regional Laboratory of the US FDA; the Belgium government's Scientific Institute of Public Health; and the Hiyoshi Corporation of Japan.Xenobiotic Detections Systems, Inc. offers analytical and and testing services with speciality in dioxins. Using genetically engineered mammalian cell lines, XDS is able to directly measure the biological response of living cells to dioxin and dioxin-like compounds to minute percentage levels.
